Toralgen Overview

  • Founded
  • 2017
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $2M
Latest Deal Amount
  • Investors
  • 2

Toralgen General Information


Operator of a biopharmaceutical company designed to focus on the development and commercialization of human therapeutics. The company's poly-bile nano-particle platform eliminates the challenges of oral delivery to fabricate nano-pill, enabling healthcare providers to improve the lives of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 1345 West 16th Street
  • Suite 300
  • Indianapolis, IN 46202
  • United States
+1 (812) 000-0000

Toralgen Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Toralgen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 10-Sep-2019 $2M 000 Completed Pre-Clinical Trials
1. Seed Round 01-Jan-2018 000 000 0000 Completed Generating Revenue
To view Toralgen’s complete valuation and funding history, request access »

Toralgen Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 000
To view Toralgen’s complete cap table history, request access »

Toralgen Executive Team (4)

Name Title Board Seat Contact Info
Gerald Rea Co-Founder & Chief Executive Officer
David Moore Chief Operating Officer
David Horwitz MD Co-Founder
Tarek Fahmy Ph.D Co-Founder
To view Toralgen’s complete executive team members history, request access »

Toralgen Board Members (1)

Name Representing Role Since
Tom Heniff Self Board Member 000 0000
To view Toralgen’s complete board members history, request access »

Toralgen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Toralgen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elevate Ventures Venture Capital Minority 000 0000 000000 0
VisionTech Partners Angel Group Minority 000 0000 000000 0
To view Toralgen’s complete investors history, request access »